Revvity

Current directors and officers who also hold a role at another S&P 500 company.

• Prahlad R. SinghAPH · Director
• Sophie Vandebroek VIDXX · Director

Latest Schedule 13D/13G filing per holder. Holders that reported falling below 5% are not shown. Index funds usually report once a year.

No 5% holder filings parsed yet for this company.

Open-market purchases and sales reported on Form 4. Grants, option exercises and tax withholding are excluded.

Every 8-K with Item 5.02 (departure, election or appointment of directors and officers). The text is the first paragraph of the item.

1. Oct 24, 2025

   On October 23, 2025, the Board of Directors (the “Board”) of Revvity, Inc. (the “Company”) appointed Anita Gonzales, the Company’s Vice President and Controller, to serve as its Vice President and Chief Accounting Officer, effective immediately. Mrs. Gonzales, 49, has served as the Company’s Vice President and Controller since May 2023, having joined the Company as Senior Director of Integration and Controllership Initiatives in March 2021. Prior to joining the Company, Mrs. Gonzales was at General Electric Company (“GE”) for ten years. During her tenure at GE, Mrs. Gonzales was Director of Audit and Advisory Practices Corporate division from 2016 to 2021, with responsibility for technical accounting and audit standards of the Corporate Audit Staff. Before that, Mrs. Gonzales held executive roles at GE Aviation including Global Controller-Commercial Engines.

   Read the 8-K filing
2. Jan 26, 2024

   On January 25, 2024, Dr. Sylvie Grégoire, a member of the Board of Directors (the “Board”) of Revvity, Inc. (“Revvity” or the “Company”) notified the Company of her decision not to stand for re-election to the Board at the annual meeting of shareholders of the Company scheduled to occur on April 23, 2024. Dr. Grégoire’s decision not to stand for re-election is not due to any disagreement between Dr. Grégoire and the Company relating to the Company’s operations, policies or practices. On January 25, 2024, the Board elected Michael A. Klobuchar and Sophie V. Vandebroek to serve on the Board, effective February 1, 2024. Neither Mr. Klobuchar nor Ms. Vandebroek will serve on a committee of the Board upon their election to the Board. In connection with their election to the Board, each of Mr. Klobuchar and Ms.

   Read the 8-K filing
3. Aug 17, 2022

   Departure of James M. Mock On August 15, 2022, James M. Mock, the Senior Vice President and Chief Financial Officer of PerkinElmer, Inc. (“PerkinElmer” or the “Company”), notified the Company that he is resigning as the Company’s Chief Financial Officer and terminating his employment effective as of September 5, 2022. Appointment of Maxwell Krakowiak On August 16, 2022, the Company’s Board of Directors (the “Board”) appointed Maxwell Krakowiak to serve as its Senior Vice President and Chief Financial Officer, effective as of September 6, 2022. He assumes the Chief Financial Officer role from James M. Mock, who has served as the Company’s Senior Vice President and Chief Financial Officer since 2018. Mr.

   Read the 8-K filing
4. Jul 22, 2022

   On July 22, 2022, the Board of Directors (the “Board”) of PerkinElmer, Inc. (“PerkinElmer” or the “Company”) elected Dr. Michelle McMurry-Heath to serve on the Board, effective immediately. In connection with her election to the Board, Dr. McMurry-Heath will receive a stock award of PerkinElmer common stock with a fair market value of $91,667 and a grant of restricted stock units with a fair market value of $75,000, representing the annual equity compensation payable to the Company’s non-employee directors under the Company’s non-employee director compensation program, prorated to reflect the remaining portion of the Board service year. Each award will be made on the customary terms and conditions of grants to PerkinElmer’s non-employee directors. In addition, Dr.

   Read the 8-K filing
5. Apr 1, 2020

   On March 26, 2020, the Compensation and Benefits Committee (the “Committee”) of the Board of Directors (the “Board”) of PerkinElmer, Inc. (the “Company”) approved a voluntary equity for salary program in which executive officers and other senior leaders of the Company are eligible to participate to show confidence in the Company’s long-term prospects. Under the program, these individuals may elect, on or prior to April 2, 2020, to defer a designated portion of their base salary over a three-month period and receive the deferred amount in the form of restricted stock units (“RSUs”) that will be granted on April 6, 2020 and will vest in full on the first anniversary of the date of grant subject to the individual’s continued service through such date.

   Read the 8-K filing
6. Mar 2, 2020

   Board of Directors On March 1, 2020, the Board of Directors (the “Board”) of PerkinElmer, Inc. (“PerkinElmer” or the “Company”) elected Michel Vounatsos to serve on the Board, effective immediately. In connection with his election to the Board, Mr. Vounatsos will receive a stock award of PerkinElmer common stock with a fair market value of $16,667 and a grant of restricted stock units with a fair market value of $12,500, representing the annual equity compensation payable to the Company’s non-employee directors under the Company’s non-employee director compensation program, prorated to reflect the remaining portion of the Board service year. Each award will be made on the customary terms and conditions of grants to PerkinElmer’s non-employee directors. In addition, Mr.

   Read the 8-K filing
7. Aug 21, 2019

   On August 21, 2019, the Board of Directors (the “Board”) of PerkinElmer, Inc. (“PerkinElmer” or the “Company”) elected Prahlad Singh to serve as the Company’s President and Chief Executive Officer, effective as of December 30, 2019, which is the first day of the Company’s 2020 fiscal year. In addition, on August 21, 2019, Dr. Singh was appointed to serve as a member of the Board effective immediately, and as a member of the Finance Committee of the Board, effective as of December 30, 2019. Dr. Singh currently serves the Company as President and Chief Operating Officer. He will assume the Chief Executive Officer role from Robert F. Friel, who will retire as an officer of the Company and member of the Board as of December 29, 2019. Mr. Friel will then serve as Special Advisor to the Company until March 1, 2020. On August 21, 2019, the Board also elected Alexis P.

   Read the 8-K filing
8. Apr 24, 2019

   2019 Incentive Plan On April 23, 2019, the shareholders of PerkinElmer, Inc. (the “Company”) approved the Company’s 2019 Incentive Plan (the “2019 Plan”), which was previously approved by the board of directors of the Company (the “Board”) on January 24, 2019. The 2019 Plan is intended to replace the Company’s 2009 Incentive Plan (the “2009 Plan”), which is scheduled to expire by its own terms on April 28, 2019. Effective as of April 23, 2019, no additional awards will be made under the 2009 Plan. Upon the expiration of the 2009 Plan, all then-outstanding awards under the 2009 Plan will remain in effect. Upon shareholder approval of the 2019 Plan, a total of 6,250,000 shares of the Company’s common stock (“Common Stock”) became available for grant under the 2019 Plan.

   Read the 8-K filing
9. Apr 12, 2019

   Pursuant to a conversation on April 8, 2019 between PerkinElmer, Inc. (the “Company”) and James Corbett, the Company’s Executive Vice President and President, Discovery & Analytical Solutions of the Company, Mr. Corbett’s employment with the Company will conclude as of April 30, 2019. In connection therewith, the Compensation and Benefits Committee of the Company’s Board of Directors has approved a modification to a previous grant of 9,747 shares of restricted stock to Mr. Corbett made pursuant to the Company’s 2009 Incentive Plan. Those shares, which had been scheduled to fully vest on October 17, 2019, will instead fully vest, subject to applicable withholdings, on April 30, 2019. Mr. Corbett is also entitled to receive certain payments and benefits from the Company pursuant to his Employment Agreement with the Company dated as of February 1, 2012.

   Read the 8-K filing
10. Dec 13, 2018

    On December 7, 2018, the Board of Directors (the “Board”) of PerkinElmer, Inc. (“PerkinElmer” or the “Company”) elected Prahlad Singh to serve as the Company’s President and Chief Operating Officer, effective as of January 1, 2019. Dr. Singh currently serves the Company as Executive Vice President and President, Diagnostics. He will assume the President role from Robert F. Friel, who will remain the Company’s Chairman and Chief Executive Officer. Dr. Singh joined the Company in 2014 as President of the Diagnostics business. He was elected Senior Vice President in 2016 and Executive Vice President in March 2018. Dr. Singh was General Manager of GE Healthcare’s Women’s Health Business from 2012 to 2014, with responsibility for the mammography and bone densitometry businesses. Prior to that, Dr.

    Read the 8-K filing
11. Apr 13, 2018

    On April 10, 2018, the Board of Directors (the “Board”) of PerkinElmer, Inc. (“PerkinElmer” or the “Company”) elected James M. Mock to serve as its Senior Vice President and Chief Financial Officer, effective as of May 1, 2018. He assumes the Chief Financial Officer role from Frank A. Wilson, who has served as the Company’s Senior Vice President and Chief Financial Officer since 2009. As previously announced, Mr. Wilson will no longer act as principal financial officer of the Company upon Mr. Mock’s commencement of service. Mr.

    Read the 8-K filing
12. Oct 30, 2017

    Board of Directors On October 27, 2017, the Board of Directors (the “Board”) of PerkinElmer, Inc. (“PerkinElmer” or the “Company”) elected Pascale Witz to serve on the Board, effective immediately. In connection with her election to the Board, Ms. Witz will receive a stock award of PerkinElmer common stock with a fair market value of $58,333, and a grant of restricted stock units with a fair market value of $43,750, representing the annual equity compensation payable to the Company’s non-employee directors under the Company’s non-employee director compensation program, prorated to reflect the remaining portion of the Board service year. Each award will be made on the customary terms and conditions of grants to PerkinElmer’s non-employee directors. In addition, Ms.

    Read the 8-K filing
13. Sep 15, 2017

    On September 12, 2017, Frank A. Wilson, Senior Vice President and Chief Financial Officer of PerkinElmer, Inc. (the “Company”) notified the Company that he will retire in August 2018.

    Read the 8-K filing
14. Jan 27, 2017

    On January 26, 2017, the Compensation and Benefits Committee of the Board of Directors of PerkinElmer, Inc. (the “Company”) adopted forms of award agreements for use under the Company’s 2009 Incentive Plan for the following types of awards: • restricted stock intended to constitute qualified performance-based compensation under Section 162(m) of the Internal Revenue Code (“Section 162(m)”) subject to time-and performance-based vesting, with full acceleration upon a change in control of the Company (“Single-Trigger Acceleration”); • restricted stock intended to constitute qualified performance-based compensation under Section 162(m) subject to time- and performance-based vesting, with full acceleration upon the award recipient’s termination without cause or resignation for good reason within 36 months following a change in control of the Company (“Double-Trigger Acceleration”); • restrict…

    Read the 8-K filing
15. Oct 17, 2016

    Board of Directors On October 15, 2016, the Board of Directors (the “Board”) of PerkinElmer, Inc. (“PerkinElmer” or the “Company”) elected Samuel R. Chapin to serve on the Board, effective immediately. In connection with his election to the Board, Mr. Chapin will receive a stock award of PerkinElmer common stock with a fair market value of $58,333 and a grant of restricted stock units with a fair market value of $43,750, representing the annual equity compensation payable to the Company’s non-employee directors under the Company’s non-employee director compensation program, prorated to reflect the remaining portion of the Board service year. Each award will be made on the customary terms and conditions of grants to PerkinElmer’s non-employee directors. In addition, Mr.

    Read the 8-K filing

Proxy statements (DEF 14A): 2026 · 2025 · 2024 · 2023 · 2022 · 2021

From the company's 10-K XBRL data (SEC companyfacts).

People who stopped filing as an insider of this company. “Last filing” is the last Form 3/4/5, an upper bound on when they left.